NewAmsterdam Pharma Co N.V. Marketable Securities, Current in USD from Q4 2024 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
NewAmsterdam Pharma Co N.V. quarterly Marketable Securities, Current history and growth rate from Q4 2024 to Q3 2025.
  • NewAmsterdam Pharma Co N.V. Marketable Securities, Current for the quarter ending September 30, 2025 was $165M.
Marketable Securities, Current, Quarterly (USD)

NewAmsterdam Pharma Co N.V. Quarterly Marketable Securities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $165M Sep 30, 2025 10-Q 2025-11-05
Q2 2025 $175M Jun 30, 2025 10-Q 2025-08-06
Q1 2025 $60.1M Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $62.4M Dec 31, 2024 10-Q 2025-11-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.